Evidence for a potential protective effect of carnitine-pantothenic acid co-treatment on valproic acid-induced hepatotoxicity
Authors:
- Alexandra LynnALAlexandra Lynn
- Sue WangSWSue Wang
- Dale E JohnsonDJDale E Johnson
- 22 January 2014
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Clinical Pharmacology
- Vol. 7 (2) , 211-218
Abstract
Valproic acid is approved for treatment of seizures and manic episodes of bipolar disorder, and continues to be one of the most commonly prescribed antiepileptic drugs in the world. Hepatotoxicity is a rare but serious side effect resulting from its use, particularly in young patients. This adverse effect does not display normal dose-response curves and can be lethal in children. A review of the purported mechanisms of action suggest hepatotoxicity results from increased oxidative stress, caused by a reduction in beta-oxidation and an increase in activation of certain metabolizing enzymes. There is also evidence that both carnitine and pantothenic acid are involved in the regulation of valproic acid-induced hepatotoxic processes, and clinical evidence has shown that treatment with either compound shows protective effects against hepatotoxicity. These results suggest a potential increase in protective effects with cotreatment of carnitine and pantothenic acid.Keywords
This publication has 40 references indexed in Scilit:
- Assessment of the role of in situ generated (E)-2,4-diene-valproic acid in the toxicity of valproic acid and (E)-2-ene-valproic acid in sandwich-cultured rat hepatocytesToxicology and Applied Pharmacology, 2012
- A new approach on valproic acid induced hepatotoxicity: Involvement of lysosomal membrane leakiness and cellular proteolysisToxicology in Vitro, 2012
- Valproic acid utilizes the isoleucine breakdown pathway for its complete β-oxidationBiochemical Pharmacology, 2011
- Effects of Valproic Acid on Organic Acid Metabolism in Children: A Metabolic Profiling StudyClinical Pharmacology & Therapeutics, 2011
- Dose‐dependent pharmacokinetics of toxic metabolites is not related to increased toxicity following high‐dose valproic acid in ratsJournal of Applied Toxicology, 2010
- Role of Oxidative Metabolism in the Effect of Valproic Acid on Markers of Cell Viability, Necrosis, and Oxidative Stress in Sandwich-Cultured Rat HepatocytesToxicological Sciences, 2010
- Drug Metabolism for the Perplexed Medicinal ChemistChemistry & Biodiversity, 2009
- Metabolomics Study With Gas Chromatography–Mass Spectrometry for Predicting Valproic Acid–induced Hepatotoxicity and Discovery of Novel Biomarkers in Rat UrineInternational Journal of Toxicology, 2009
- Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A reviewJournal of Inherited Metabolic Disease, 2008
- Accumulation and Washout Kinetics of Valproic Acid and Its Active MetabolitesThe Journal of Clinical Pharmacology, 1986